ISHRAK OMAR 4

What Happened

• Ishrak Omar, a director of Amgen Inc. (AMGN), received a grant of 665 restricted stock units (RSUs) on 2026-05-19. The reported acquisition price is $0.00 (grant/award), so the Form 4 shows $0 cash paid. The award vested immediately and is payable in shares on a one-to-one basis under the company's director incentive plan.

Key Details

• Transaction date: 2026-05-19; Report filed: 2026-05-21 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares reported: 665 RSUs granted at $0.00.
• Footnote highlights:
  • F1: RSUs were granted under Amgen’s 2009 Director Incentive Program, vested immediately, and are paid in shares (director may elect deferral).
  • F2: The 665 shares include 418 dividend equivalents (DEs) credited to unvested RSUs and paid out in shares per the vesting schedule, with cash for any fractional share.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

• This is an equity compensation award to a board member — not an open-market buy or sale. Awards to directors are routine compensation and do not necessarily signal a personal view on the stock. Deferred payout or immediate issuance depends on the director’s deferral election; DEs simply reflect dividend equivalents credited to the RSUs.